IBEX Limited is a medical technology company based in Israel that specializes in developing artificial intelligence-powered solutions for breast cancer diagnostics. The company's technology is based on a proprietary algorithm that analyzes mammograms and other medical imaging data to detect signs of breast cancer.
IBEX's main product is the Galen Breast solution, which is designed to assist pathologists in diagnosing breast cancer by analyzing digital pathology images. The Galen Breast solution uses machine learning algorithms to identify and highlight potential problem areas in the images, allowing pathologists to focus their attention on these areas and make more accurate diagnoses.
IBEX was founded in 2016 and is headquartered in Tel Aviv, Israel. The company went public on the NASDAQ stock exchange in 2021 under the ticker symbol "IBEX".
IBEX Limited is a medical technology company based in Israel that specializes in developing artificial intelligence-powered solutions for breast cancer diagnostics. The company's technology is based on a proprietary algorithm that analyzes mammograms and other medical imaging data to detect signs of breast cancer.